Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (39)
Arkaja Tripathy, Sandeep Muzumder, Nirmala Srikantia, Ajay Babu, MG John Sebastian, Avinash H. Udayashankar, Ganesha Dev Vashishta & John Michael Raj. (2023) A comparison of conventional and accelerated hypofractionated radiotherapy in definitive chemoradiation for locally advanced head and neck carcinoma: a retrospective cohort study. Radiation Oncology Journal 41:4, pages 248-257.
Crossref
Crossref
Y. Pointreau, J. Biau, N. Delaby, J. Thariat & M. Lapeyre. (2022) Radiotherapy for hypopharynx cancers. Cancer/Radiothérapie 26:1-2, pages 199-205.
Crossref
Crossref
J. Biau, Y. Pointreau, P. Blanchard, C. Khampan, P. Giraud, M. Lapeyre & P. Maingon. (2022) Radiotherapy for laryngeal cancers. Cancer/Radiothérapie 26:1-2, pages 206-212.
Crossref
Crossref
LanishaJolitha Sequeira, Sharaschandra Shankar, SandeshB Rao, Donald Fernandes, Tony Jacob & H Krishnaraj. (2022) Study of comparison of acute toxicities between sequential intensity-modulated radiation therapy and simultaneous integrated boost intensity-modulated radiation therapy in head-and-neck cancers. Journal of Radiation and Cancer Research 0:0, pages 0.
Crossref
Crossref
Archis Ghate. 2021. Tutorials in Operations Research: Emerging Optimization Methods and Modeling Techniques with Applications. Tutorials in Operations Research: Emerging Optimization Methods and Modeling Techniques with Applications
1
37
.
Jared Weddell, Manoj S. Chiney, Sumit Bhatnagar, John P. Gibbs & Mohamad Shebley. (2020) Mechanistic Modeling of Intra‐Tumor Spatial Distribution of Antibody‐Drug Conjugates: Insights into Dosing Strategies in Oncology. Clinical and Translational Science 14:1, pages 395-404.
Crossref
Crossref
Francesca De Felice, Pierluigi Bonomo, Giuseppe Sanguineti & Ester Orlandi. (2020) Moderately accelerated intensity‐modulated radiation therapy using simultaneous integrated boost: Practical reasons or evidence‐based choice? A critical appraisal of literature. Head & Neck 42:11, pages 3405-3414.
Crossref
Crossref
Shao Hui Huang, Brian O’Sullivan, Jie Su, Jolie Ringash, Scott V. Bratman, John Kim, Ali Hosni, Andrew Bayley, John Cho, Meredith Giuliani, Andrew Hope, Anna Spreafico, Aaron R. Hansen, Lillian L. Siu, Ralph Gilbert, Jonathan C. Irish, David Goldstein, John Almeida, Li Tong, Wei Xu & John Waldron. (2020) Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID‐19 pandemic: The Princess Margaret experience and proposal. Cancer 126:15, pages 3426-3437.
Crossref
Crossref
D. Atwell, J. Elks, K. Cahill, N. Hearn, D. Vignarajah, J. Lagopoulos & M. Min. (2020) A Review of Modern Radiation Therapy Dose Escalation in Locally Advanced Head and Neck Cancer. Clinical Oncology 32:5, pages 330-341.
Crossref
Crossref
P. Blanchard, J. Biau, J. Castelli, Y. Tao, P. Graff & F. Nguyen. (2019) Personnalisation de la dose et du fractionnement de la radiothérapie des cancers de la tête et du cou. Cancer/Radiothérapie 23:6-7, pages 784-788.
Crossref
Crossref
Sevnaz Nourollahi, Archis Ghate & Minsun Kim. (2019) Optimal modality selection in external beam radiotherapy. Mathematical Medicine and Biology: A Journal of the IMA 36:3, pages 361-380.
Crossref
Crossref
Li Jiang, Yong Zhang, Zhendong Yang, Feifei Liang, Jiangtao Wu & Rensheng Wang. (2019) A comparison of clinical outcomes between simultaneous integrated boost (SIB) versus sequential boost (SEQ) intensity modulated radiation therapy (IMRT) for head and neck cancer. Medicine 98:34, pages e16942.
Crossref
Crossref
Kathy Rock, Shao Hui Huang, Albert Tiong, Lin Lu, Wei Xu, Jolie Ringash, Scott V. Bratman, Li Tong, Biu Chan, John Cho, Meredith Giuliani, Andrew Hope, Andrew Bayley, John Kim, John R. de Almeida, Brian O'Sullivan & John Waldron. (2018) Partial Laryngeal IMRT for T2N0 Glottic Cancer: Impact of Image Guidance and Radiation Therapy Intensification. International Journal of Radiation Oncology*Biology*Physics 102:4, pages 941-949.
Crossref
Crossref
S. Meade, P. Gaunt, A. Hartley, M. Robinson, V. Harrop, J. Cashmore, L. Wagstaff, J. Babrah, S.J. Bowden, H. Mehanna & P. Sanghera. (2018) Feasibility of Dose-escalated Hypofractionated Chemoradiation in Human Papilloma Virus-negative or Smoking-associated Oropharyngeal Cancer. Clinical Oncology 30:6, pages 366-374.
Crossref
Crossref
Osamah S. Malallah, Cristina M. Aller Garcia, Gordon B. Proctor, Ben Forbes & Paul G. Royall. (2018) Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth). International Journal of Pharmaceutics 541:1-2, pages 157-166.
Crossref
Crossref
Cristhian Camilo Madrid Troconis, Alan Roger Santos-Silva, Thaís Bianca Brandão, Marcio Ajudarte Lopes & Mario Fernando de Goes. (2017) Impact of head and neck radiotherapy on the mechanical behavior of composite resins and adhesive systems: A systematic review. Dental Materials 33:11, pages 1229-1243.
Crossref
Crossref
Fatemeh Saberian, Archis Ghate & Minsun Kim. (2017) Spatiotemporally Optimal Fractionation in Radiotherapy. INFORMS Journal on Computing 29:3, pages 422-437.
Crossref
Crossref
Michael T. Spiotto & Matthew Koshy. (2017) Impact of fraction size on locally advanced oropharyngeal and nasopharyngeal cancers treated with chemoradiation. Oral Oncology 68, pages 27-35.
Crossref
Crossref
Y. Pointreau, C. Lafond, F. Legouté, P. Trémolières, S. Servagi-Vernat, P. Giraud, P. Maingon, G. Calais & M. Lapeyre. (2016) Radiothérapie des cancers du larynx. Cancer/Radiothérapie 20, pages S131-S135.
Crossref
Crossref
Lei Du, Xin Xin Zhang, Lin Chun Feng, Jing Chen, Jun Yang, Hai Xia Liu, Shou Ping Xu, Chuan Bin Xie & Lin Ma. (2016) Treatment of nasopharyngeal carcinoma using simultaneous modulated accelerated radiation therapy via helical tomotherapy: a phase II study. Radiology and Oncology 50:2, pages 218-225.
Crossref
Crossref
Tejpal Gupta, Sadhana Kannan, Sarbani Ghosh-Laskar & Jai Prakash Agarwal. (2015) Concomitant chemoradiotherapy versus altered fractionation radiotherapy in the radiotherapeutic management of locoregionally advanced head and neck squamous cell carcinoma: An adjusted indirect comparison meta-analysis. Head & Neck 37:5, pages 670-676.
Crossref
Crossref
S. Yossi, C. El Alouani, Y. Pointreau, L. Laccourreye, O. Capitain, P. Gustin, G. Peyraga, A.-L. Septans, É. Jadaud, S. Vinchon-Petit, P. Cellier, D. Autret & C. Tuchais. (2015) Sites de récidive après radiothérapie conformationnelle avec modulation d’intensité des carcinomes épidermoïdes des voies aérodigestives supérieures. Cancer/Radiothérapie 19:2, pages 73-81.
Crossref
Crossref
Ercole Mazzeo, Paolo Antognoni, Manuela Parmiggiani, Consuelo D'Ambrosio, Giuseppina De Marco, Laura Marra, Giovanni Gottardi & Filippo Bertoni. (2018) IMRT-SIB with Concurrent and Neo-Adjuvant Platinum-Based Chemotherapy for Locally Advanced Head and Neck Squamous Cell Cancer: Analysis of Clinical Outcomes in a Retrospective Series of a Single Institution. Tumori Journal 100:6, pages 652-659.
Crossref
Crossref
E. Gkika, T. Gauler, W. Eberhardt, M. Stahl, M. Stuschke & C. Pöttgen. (2014) Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus. Diseases of the Esophagus 27:7, pages 678-684.
Crossref
Crossref
Dionne M. Aleman, Johan Wallgren, H. Edwin Romeijn & James F. Dempsey. (2013) A fluence map optimization model for restoring traditional fractionation in IMRT treatment planning. Optimization Letters 8:4, pages 1453-1473.
Crossref
Crossref
Martin Stuschke, Andreas Kaiser, Jehad Abu-Jawad, Christoph Pöttgen, Sabine Levegrün & Jonathan Farr. (2013) Re-irradiation of recurrent head and neck carcinomas: comparison of robust intensity modulated proton therapy treatment plans with helical tomotherapy. Radiation Oncology 8:1.
Crossref
Crossref
Masahiro Mizuta, Seishin Takao, Hiroyuki Date, Naoki Kishimoto, Kenneth L. Sutherland, Rikiya Onimaru & Hiroki Shirato. (2012) A Mathematical Study to Select Fractionation Regimen Based on Physical Dose Distribution and the Linear–Quadratic Model. International Journal of Radiation Oncology*Biology*Physics 84:3, pages 829-833.
Crossref
Crossref
Christoph Pöttgen & Martin Stuschke. (2012) Radiotherapy versus surgery within multimodality protocols for esophageal cancer – A meta-analysis of the randomized trials. Cancer Treatment Reviews 38:6, pages 599-604.
Crossref
Crossref
Jacques Bernier & Jean-Claude Horiot. (2012) Altered-fractionated radiotherapy in locally advanced head and neck cancer. Current Opinion in Oncology 24:3, pages 223-228.
Crossref
Crossref
Theodore S. Hong, Wolfgang A. Tomé & Paul M. Harari. (2012) Heterogeneity in head and neck IMRT target design and clinical practice. Radiotherapy and Oncology 103:1, pages 92-98.
Crossref
Crossref
Fréderic Duprez, Katrien Bonte, Wilfried De Neve, Tom Boterberg, Werner De Gersem & Indira Madani. (2011) Regional Relapse After Intensity-Modulated Radiotherapy for Head-and-Neck Cancer. International Journal of Radiation Oncology*Biology*Physics 79:2, pages 450-458.
Crossref
Crossref
A.K. Chan, P. Sanghera, B.A. Choo, C. McConkey, H. Mehanna, S. Parmar, P. Pracy, J. Glaholm & A. Hartley. (2011) Hypofractionated Accelerated Radiotherapy with Concurrent Carboplatin for Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Clinical Oncology 23:1, pages 34-39.
Crossref
Crossref
Emmy Lamers-Kuijper, Wilma Heemsbergen, Anke van Mourik & Coen Rasch. (2011) Sequentially delivered boost plans are superior to simultaneously delivered plans in head and neck cancer when the boost volume is located further away from the parotid glands. Radiotherapy and Oncology 98:1, pages 51-56.
Crossref
Crossref
Brigida C Ferreira, Maria do Carmo Lopes, Josefina Mateus, Miguel Capela & Panayiotis Mavroidis. (2010) Radiobiological evaluation of forward and inverse IMRT using different fractionations for head and neck tumours. Radiation Oncology 5:1.
Crossref
Crossref
Wen-Yen Huang, Yee-Min Jen, Chang-Ming Chen, Yu-Fu Su, Chun-Shu Lin, Yaoh-Shiang Lin, Ying-Nan Chang, Hsing-Lung Chao, Kuen-Tze Lin & Li-Ping Chang. (2010) Intensity modulated radiotherapy with concurrent chemotherapy for larynx preservation of advanced resectable hypopharyngeal cancer. Radiation Oncology 5:1.
Crossref
Crossref
M. Lapeyre, C. Bailly, I. Toledano, A. Montalban & M. Russier. (2010) Cancer de l’hypopharynx et du larynx : proposition de sélection et délimitation des volumes cibles microscopiques péri-tumoraux (aires ganglionnaires exclues). Cancer/Radiothérapie 14, pages S43-S51.
Crossref
Crossref
. (2010) Current World Literature. Current Opinion in Otolaryngology & Head & Neck Surgery 18:2, pages 134-145.
Crossref
Crossref
Gupta Tejpal, Agarwal JaiPrakash, Bannerjee Susovan, Sarbani Ghosh-Laskar, Vedang Murthy & Ashwini Budrukkar. (2010) IMRT and IGRT in head and neck cancer: Have we delivered what we promised?. Indian Journal of Surgical Oncology 1:2, pages 166-185.
Crossref
Crossref
Rainald Knecht. 2010. Handbuch HNO 2009. Handbuch HNO 2009
311
354
.